Skip to main content
Top
Published in: BMC Gastroenterology 1/2013

Open Access 01-12-2013 | Research article

Different healing process of esophageal large mucosal defects by endoscopic mucosal dissection between with and without steroid injection in an animal model

Authors: Kouichi Nonaka, Mitsuo Miyazawa, Shinichi Ban, Masayasu Aikawa, Naoe Akimoto, Isamu Koyama, Hiroto Kita

Published in: BMC Gastroenterology | Issue 1/2013

Login to get access

Abstract

Background

Stricture formation is one of the major complications after endoscopic removal of large superficial squamous cell neoplasms of the esophagus, and local steroid injections have been adopted to prevent it. However, fundamental pathological alterations related to them have not been well analyzed so far. The aim of this study was to analyze the time course of the healing process of esophageal large mucosal defects resulting in stricture formation and its modification by local steroid injection, using an animal model.

Methods

Esophageal circumferential mucosal defects were created by endoscopic mucosal dissection (ESD) for four pigs. One pig was sacrificed five minutes after the ESD, and other two pigs were followed-up on endoscopy and sacrificed at the time of one week and three weeks after the ESD, respectively. The remaining one pig was followed-up on endoscopy with five times of local steroid injection and sacrificed at the time of eight weeks after the ESD. The esophageal tissues of all pigs were subjected to pathological analyses.

Results

For the pigs without steroid injection, the esophageal stricture was completed around three weeks after the ESD on both endoscopy and esophagography. Histopathological examination of the esophageal tissues revealed that spindle-shaped α-smooth muscle actin (SMA)-positive myofibroblasts arranged in a parallel fashion and extending horizontally were identified at the ulcer bed one week after the ESD, and increased contributing to formation of the stenotic luminal ridge covered with the regenerated epithelium three weeks after the ESD. The proper muscle layer of the stricture site was thinned with some myocytes which seemingly showed transition to the myofibroblast layer. By contrast, for the pig with steroid injection, esophageal stricture formation was not evident with limited appearance of the spindle-shaped myofibroblasts, instead, appearance of stellate or polygocal SMA-positive stromal cells arranged haphazardly in the persistent granulation tissue of the ulcer site.

Conclusions

Proliferation of spindle-shaped myofibroblasts arranged in a parallel fashion is likely to play an important role in stricture formation after circumferential mucosal defects by esophageal ESD, which may be related to the thinning of the proper muscle layer in the healing course of the defects. Local steroid injection seems to be effective to prevent the stricture through the modification of this process.
Appendix
Available only for authorised users
Literature
1.
go back to reference Endo M, Takeshita K, Yoshida M: How can we diagnose the early stage of esophageal cancer? Endoscopic diagnosis. Endoscopy. 1986, 18 (Suppl 3): 11-18.CrossRefPubMed Endo M, Takeshita K, Yoshida M: How can we diagnose the early stage of esophageal cancer? Endoscopic diagnosis. Endoscopy. 1986, 18 (Suppl 3): 11-18.CrossRefPubMed
2.
go back to reference Mandard AM, Tourneux J, Gignoux M: In situ carcinoma of the esophagus. Macroscopic study with particular reference to the Lugol test. Endoscopy. 1980, 12: 51-57. 10.1055/s-2007-1021710.CrossRefPubMed Mandard AM, Tourneux J, Gignoux M: In situ carcinoma of the esophagus. Macroscopic study with particular reference to the Lugol test. Endoscopy. 1980, 12: 51-57. 10.1055/s-2007-1021710.CrossRefPubMed
3.
go back to reference Muto M, Minashi K, Yano T: Early detection of superficial squamous cell carcinoma in the head and neck region and esophagus by narrow band imaging: a multicenter randomized controlled trial. J Clin Oncol. 2010, 28: 1566-1572. 10.1200/JCO.2009.25.4680.CrossRefPubMedPubMedCentral Muto M, Minashi K, Yano T: Early detection of superficial squamous cell carcinoma in the head and neck region and esophagus by narrow band imaging: a multicenter randomized controlled trial. J Clin Oncol. 2010, 28: 1566-1572. 10.1200/JCO.2009.25.4680.CrossRefPubMedPubMedCentral
4.
go back to reference Makuuchi H: Endoscopic mucosal resection for mucosal cancer in the esophagus. Gastrointest Endosc Clin N Am. 2001, 11: 445-458.PubMed Makuuchi H: Endoscopic mucosal resection for mucosal cancer in the esophagus. Gastrointest Endosc Clin N Am. 2001, 11: 445-458.PubMed
5.
go back to reference McCulloch P, Ward J, Tekkis PP: Mortality and morbidity in gastro-oesophageal cancer surgery: initial results of ASCOT multicentre prospective cohort study. BMJ. 2003, 327: 1192-1197. 10.1136/bmj.327.7425.1192.CrossRefPubMedPubMedCentral McCulloch P, Ward J, Tekkis PP: Mortality and morbidity in gastro-oesophageal cancer surgery: initial results of ASCOT multicentre prospective cohort study. BMJ. 2003, 327: 1192-1197. 10.1136/bmj.327.7425.1192.CrossRefPubMedPubMedCentral
6.
go back to reference Karl RC, Schreiber R, Boulware D, Baker S, Coppola D: Factors affecting morbidity, mortality, and survival in patients undergoing ivor lewis esophagogastrectomy. Ann Surg. 2000, 231: 635-643. 10.1097/00000658-200005000-00003.CrossRefPubMedPubMedCentral Karl RC, Schreiber R, Boulware D, Baker S, Coppola D: Factors affecting morbidity, mortality, and survival in patients undergoing ivor lewis esophagogastrectomy. Ann Surg. 2000, 231: 635-643. 10.1097/00000658-200005000-00003.CrossRefPubMedPubMedCentral
7.
go back to reference Shimizu Y, Tsukagoshi H, Fujita M: Long-term outcome after endoscopic mucosal resection in patients with esophageal squamous cell carcinoma invading the muscularis mucosae or deeper. Gastrointest Endosc. 2002, 56: 387-390. 10.1016/S0016-5107(02)70043-6.CrossRefPubMed Shimizu Y, Tsukagoshi H, Fujita M: Long-term outcome after endoscopic mucosal resection in patients with esophageal squamous cell carcinoma invading the muscularis mucosae or deeper. Gastrointest Endosc. 2002, 56: 387-390. 10.1016/S0016-5107(02)70043-6.CrossRefPubMed
8.
go back to reference Fujita H, Sueyoshi S, Yamana H: Optimum treatment strategy for superficial esophageal cancer: endoscopic mucosal resection versus radical esophagectomy. World J Surg. 2001, 25: 424-431. 10.1007/s002680020053.CrossRefPubMed Fujita H, Sueyoshi S, Yamana H: Optimum treatment strategy for superficial esophageal cancer: endoscopic mucosal resection versus radical esophagectomy. World J Surg. 2001, 25: 424-431. 10.1007/s002680020053.CrossRefPubMed
9.
go back to reference Yamamoto H, Yube T, Isoda N: A novel method of endoscopic mucosal resection using sodium hyaluronate. Gastrointest Endosc. 1999, 50: 251-256. 10.1016/S0016-5107(99)70234-8.CrossRefPubMed Yamamoto H, Yube T, Isoda N: A novel method of endoscopic mucosal resection using sodium hyaluronate. Gastrointest Endosc. 1999, 50: 251-256. 10.1016/S0016-5107(99)70234-8.CrossRefPubMed
10.
11.
go back to reference Fujishiro M, Yahagi N, Kakushima N: Endoscopic submucosal dissection of esophageal squamous cell neoplasms. Clin Gastroenterol Hepatol. 2006, 4: 688-694. 10.1016/j.cgh.2006.03.024.CrossRefPubMed Fujishiro M, Yahagi N, Kakushima N: Endoscopic submucosal dissection of esophageal squamous cell neoplasms. Clin Gastroenterol Hepatol. 2006, 4: 688-694. 10.1016/j.cgh.2006.03.024.CrossRefPubMed
12.
go back to reference Nonaka K, Arai S, Ishikawa K: Short term results of endoscopic submucosal dissection superficial esophageal squamous cell neoplasms. World J Gastrointest Endosc. 2010, 16: 69-74.CrossRef Nonaka K, Arai S, Ishikawa K: Short term results of endoscopic submucosal dissection superficial esophageal squamous cell neoplasms. World J Gastrointest Endosc. 2010, 16: 69-74.CrossRef
13.
go back to reference Mizuta H, Nishimori I, Kuratani Y: Predictive factors for esophageal stenosis after endoscopic submucosal dissection for superficial esophageal cancer. Dis Esophagus. 2009, 22: 626-631. 10.1111/j.1442-2050.2009.00954.x.CrossRefPubMed Mizuta H, Nishimori I, Kuratani Y: Predictive factors for esophageal stenosis after endoscopic submucosal dissection for superficial esophageal cancer. Dis Esophagus. 2009, 22: 626-631. 10.1111/j.1442-2050.2009.00954.x.CrossRefPubMed
14.
go back to reference Ashcraft KW, Holder TM: The expeimental treatment of esophageal strictures by intralesional steroid injections. J Thorac Cardiovasc Surg. 1969, 58: 685-691. passimPubMed Ashcraft KW, Holder TM: The expeimental treatment of esophageal strictures by intralesional steroid injections. J Thorac Cardiovasc Surg. 1969, 58: 685-691. passimPubMed
15.
go back to reference Holder TM, Ashcraft KW, Leape L: The treatment of patients with esophageal strictures by local steroid injections. J Pediatr Surg. 1969, 4: 646-653. 10.1016/0022-3468(69)90492-8.CrossRefPubMed Holder TM, Ashcraft KW, Leape L: The treatment of patients with esophageal strictures by local steroid injections. J Pediatr Surg. 1969, 4: 646-653. 10.1016/0022-3468(69)90492-8.CrossRefPubMed
16.
go back to reference Kochhar R, Ray JD, Sriram PV, Kumar S, Singh K: Intralesional steroids augment the effects of endoscopic dilation in corrosive esophageal strictures. Gastrointest Endosc. 1999, 49: 509-513. 10.1016/S0016-5107(99)70052-0.CrossRefPubMed Kochhar R, Ray JD, Sriram PV, Kumar S, Singh K: Intralesional steroids augment the effects of endoscopic dilation in corrosive esophageal strictures. Gastrointest Endosc. 1999, 49: 509-513. 10.1016/S0016-5107(99)70052-0.CrossRefPubMed
17.
go back to reference Kochhar R, Makharia GK: Usefulness of intralesional triamcinolone in treatment of benign esophageal strictures. Gastrointest Endosc. 2002, 56: 829-834. 10.1016/S0016-5107(02)70355-6.CrossRefPubMed Kochhar R, Makharia GK: Usefulness of intralesional triamcinolone in treatment of benign esophageal strictures. Gastrointest Endosc. 2002, 56: 829-834. 10.1016/S0016-5107(02)70355-6.CrossRefPubMed
18.
go back to reference Ramage JI, Rumalla A, Baron TH: A prospective, randomized, double-blind, placebo-controlled trial of endoscopic steroid injection therapy for recalcitrant esophageal peptic strictures. Am J Gastroenterol. 2005, 100: 2419-2425. 10.1111/j.1572-0241.2005.00331.x.CrossRefPubMed Ramage JI, Rumalla A, Baron TH: A prospective, randomized, double-blind, placebo-controlled trial of endoscopic steroid injection therapy for recalcitrant esophageal peptic strictures. Am J Gastroenterol. 2005, 100: 2419-2425. 10.1111/j.1572-0241.2005.00331.x.CrossRefPubMed
19.
go back to reference Gandhi RP, Cooper A, Barlow BA: Successful management of esophageal strictures without resection or replacement. J Pediatr Surg. 1989, 24: 745-749. 10.1016/S0022-3468(89)80529-9. discussion 749–750CrossRefPubMed Gandhi RP, Cooper A, Barlow BA: Successful management of esophageal strictures without resection or replacement. J Pediatr Surg. 1989, 24: 745-749. 10.1016/S0022-3468(89)80529-9. discussion 749–750CrossRefPubMed
20.
go back to reference Altintas E, Kacar S, Tunc B: Intralesional steroid injection in benign esophageal strictures resistant to bougie dilation. J Gastroenterol Hepatol. 2004, 19: 1388-1391. 10.1111/j.1440-1746.2004.03491.x.CrossRefPubMed Altintas E, Kacar S, Tunc B: Intralesional steroid injection in benign esophageal strictures resistant to bougie dilation. J Gastroenterol Hepatol. 2004, 19: 1388-1391. 10.1111/j.1440-1746.2004.03491.x.CrossRefPubMed
21.
go back to reference Hashimoto S, Kobayashi M, Takeuchi M: The efficacy of endoscopic triamcinolone injection for the prevention of esophageal stricture after endoscopic submucosal dissection. Gastrointest Endosc. 2011, 74: 1389-1393. 10.1016/j.gie.2011.07.070.CrossRefPubMed Hashimoto S, Kobayashi M, Takeuchi M: The efficacy of endoscopic triamcinolone injection for the prevention of esophageal stricture after endoscopic submucosal dissection. Gastrointest Endosc. 2011, 74: 1389-1393. 10.1016/j.gie.2011.07.070.CrossRefPubMed
22.
go back to reference Isomoto H, Yamaguchi N, Nakayama T: Management of esophageal stricture after complete circular endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma. BMC Gastroenterol. 2011, 11: 46-10.1186/1471-230X-11-46.CrossRefPubMedPubMedCentral Isomoto H, Yamaguchi N, Nakayama T: Management of esophageal stricture after complete circular endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma. BMC Gastroenterol. 2011, 11: 46-10.1186/1471-230X-11-46.CrossRefPubMedPubMedCentral
23.
go back to reference Kita H, Yamamoto H, Miyata T: Endoscopic submucosal dissection using sodium hyaluronate, a new technique for en bloc resection of a large superficial tumor in the colon. Inflammopharmacology. 2007, 15: 129-131. 10.1007/s10787-007-1572-6.CrossRefPubMed Kita H, Yamamoto H, Miyata T: Endoscopic submucosal dissection using sodium hyaluronate, a new technique for en bloc resection of a large superficial tumor in the colon. Inflammopharmacology. 2007, 15: 129-131. 10.1007/s10787-007-1572-6.CrossRefPubMed
24.
go back to reference Nieponice A, McGrath K, Qureshi I: An extracellular matrix scaffold for esophageal stricture prevention after circumferential EMR. Gastrointest Endosc. 2009, 69: 289-296. 10.1016/j.gie.2008.04.022.CrossRefPubMed Nieponice A, McGrath K, Qureshi I: An extracellular matrix scaffold for esophageal stricture prevention after circumferential EMR. Gastrointest Endosc. 2009, 69: 289-296. 10.1016/j.gie.2008.04.022.CrossRefPubMed
25.
go back to reference Sakurai T, Miyazaki S, Miyata G, Satomi S, Hori Y: Autologous buccal keratinocyte implantation for the prevention of stenosis after EMR of the esophagus. Gastrointest Endosc. 2007, 66: 167-173. 10.1016/j.gie.2006.12.062.CrossRefPubMed Sakurai T, Miyazaki S, Miyata G, Satomi S, Hori Y: Autologous buccal keratinocyte implantation for the prevention of stenosis after EMR of the esophagus. Gastrointest Endosc. 2007, 66: 167-173. 10.1016/j.gie.2006.12.062.CrossRefPubMed
26.
go back to reference Honda M, Hori Y, Nakada A: Use of adipose tissue-derived stromal cells for prevention of esophageal stricture after circumferential EMR in a canine model. Gastrointest Endosc. 2011, 73: 777-784. 10.1016/j.gie.2010.11.008.CrossRefPubMed Honda M, Hori Y, Nakada A: Use of adipose tissue-derived stromal cells for prevention of esophageal stricture after circumferential EMR in a canine model. Gastrointest Endosc. 2011, 73: 777-784. 10.1016/j.gie.2010.11.008.CrossRefPubMed
27.
go back to reference Ono S, Fujishiro M, Niimi K: Predictors of postoperative stricture after esophageal endoscopic submucosal dissection for superficial squamous cell neoplasms. Endoscopy. 2009, 41: 661-665. 10.1055/s-0029-1214867.CrossRefPubMed Ono S, Fujishiro M, Niimi K: Predictors of postoperative stricture after esophageal endoscopic submucosal dissection for superficial squamous cell neoplasms. Endoscopy. 2009, 41: 661-665. 10.1055/s-0029-1214867.CrossRefPubMed
28.
go back to reference Lew RJ, Kochman ML: A review of endoscopic methods of esophageal dilation. J Clin Gastroenterol. 2002, 35: 117-126. 10.1097/00004836-200208000-00001.CrossRefPubMed Lew RJ, Kochman ML: A review of endoscopic methods of esophageal dilation. J Clin Gastroenterol. 2002, 35: 117-126. 10.1097/00004836-200208000-00001.CrossRefPubMed
29.
30.
go back to reference Honda M, Nakamura T, Hori Y: Process of healing of mucosal defects in the esophagus after endoscopic mucosal resection: histological evaluation in a dog model. Endoscopy. 2010, 42: 1092-1095. 10.1055/s-0030-1255741.CrossRefPubMed Honda M, Nakamura T, Hori Y: Process of healing of mucosal defects in the esophagus after endoscopic mucosal resection: histological evaluation in a dog model. Endoscopy. 2010, 42: 1092-1095. 10.1055/s-0030-1255741.CrossRefPubMed
31.
go back to reference Dolgachev VA, Ullenbruch MR, Lukacs NW, Phan SH: Role of stem cell factor and bone marrow-derived fibroblasts in airway remodeling. Am J Pathol. 2009, 174: 390-400. 10.2353/ajpath.2009.080513.CrossRefPubMedPubMedCentral Dolgachev VA, Ullenbruch MR, Lukacs NW, Phan SH: Role of stem cell factor and bone marrow-derived fibroblasts in airway remodeling. Am J Pathol. 2009, 174: 390-400. 10.2353/ajpath.2009.080513.CrossRefPubMedPubMedCentral
32.
go back to reference Ichikawa T, Sugiura H, Koarai A: Peroxynitrite augments fibroblast-mediated tissue remodeling via myofibroblast differentiation. Am J Physiol Lung Cell Mol Physiol. 2008, 295: L800-L808. 10.1152/ajplung.90264.2008.CrossRefPubMed Ichikawa T, Sugiura H, Koarai A: Peroxynitrite augments fibroblast-mediated tissue remodeling via myofibroblast differentiation. Am J Physiol Lung Cell Mol Physiol. 2008, 295: L800-L808. 10.1152/ajplung.90264.2008.CrossRefPubMed
33.
go back to reference Kelly MM, O'Connor TM, Leigh R: Effects of budesonide and formoterol on allergen-induced airway responses, inflammation, and airway remodeling in asthma. J Allergy Clin Immunol. 2010, 125: 349-356. 10.1016/j.jaci.2009.09.011. e313CrossRefPubMed Kelly MM, O'Connor TM, Leigh R: Effects of budesonide and formoterol on allergen-induced airway responses, inflammation, and airway remodeling in asthma. J Allergy Clin Immunol. 2010, 125: 349-356. 10.1016/j.jaci.2009.09.011. e313CrossRefPubMed
34.
go back to reference Suekane T, Ikura Y, Watanabe K: Phenotypic change and accumulation of smooth muscle cells in strictures in Crohn's disease: relevance to local angiotensin II system. J Gastroenterol. 2010, 45: 821-830. 10.1007/s00535-010-0232-6.CrossRefPubMed Suekane T, Ikura Y, Watanabe K: Phenotypic change and accumulation of smooth muscle cells in strictures in Crohn's disease: relevance to local angiotensin II system. J Gastroenterol. 2010, 45: 821-830. 10.1007/s00535-010-0232-6.CrossRefPubMed
35.
go back to reference Li Y, Foster W, Deasy BM: Transforming growth factor-beta1 induces the differentiation of myogenic cells into fibrotic cells in injured skeletal muscle: a key event in muscle fibrogenesis. Am J Pathol. 2004, 164: 1007-1019. 10.1016/S0002-9440(10)63188-4.CrossRefPubMedPubMedCentral Li Y, Foster W, Deasy BM: Transforming growth factor-beta1 induces the differentiation of myogenic cells into fibrotic cells in injured skeletal muscle: a key event in muscle fibrogenesis. Am J Pathol. 2004, 164: 1007-1019. 10.1016/S0002-9440(10)63188-4.CrossRefPubMedPubMedCentral
36.
go back to reference De Wever O, Demetter P, Mareel M, Bracke M: Stromal myofibroblasts are drivers of invasive cancer growth. Int J Cancer. 2008, 123: 2229-2238. 10.1002/ijc.23925.CrossRefPubMed De Wever O, Demetter P, Mareel M, Bracke M: Stromal myofibroblasts are drivers of invasive cancer growth. Int J Cancer. 2008, 123: 2229-2238. 10.1002/ijc.23925.CrossRefPubMed
37.
go back to reference Ishii G, Sangai T, Oda T: Bone-marrow-derived myofibroblasts contribute to the cancer-induced stromal reaction. Biochem Biophys Res Commun. 2003, 309: 232-240. 10.1016/S0006-291X(03)01544-4.CrossRefPubMed Ishii G, Sangai T, Oda T: Bone-marrow-derived myofibroblasts contribute to the cancer-induced stromal reaction. Biochem Biophys Res Commun. 2003, 309: 232-240. 10.1016/S0006-291X(03)01544-4.CrossRefPubMed
Metadata
Title
Different healing process of esophageal large mucosal defects by endoscopic mucosal dissection between with and without steroid injection in an animal model
Authors
Kouichi Nonaka
Mitsuo Miyazawa
Shinichi Ban
Masayasu Aikawa
Naoe Akimoto
Isamu Koyama
Hiroto Kita
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2013
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/1471-230X-13-72

Other articles of this Issue 1/2013

BMC Gastroenterology 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.